Press Releases
22 August 2019
Appoints veteran VP Operations Hires high profile cannabis sommelier LAVAL, QC, Aug. 22, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce two new additions to its team to support the company's rapid growth. Neptune has appointed
Read more...22 August 2019
DENVER, Aug. 22, 2019 /PRNewswire/ -- DAVITA INC. (NYSE: DVA), "DaVita," a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today the final results of its modified "Dutch auction" te
Read more...22 August 2019
NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Oscar, the first health insurance company built to make health care easy, today announced that it will expand to cover individuals and families in six new states and a total of 12 new markets in 2020, pending regulatory approval. This is the third consecutive year Oscar has significantly expanded its footprint, and this expansion b
Read more...22 August 2019
LINKÖPING, Sweden, Aug. 22, 2019 /PRNewswire/ -- Linköping, Sweden – August 22, 2019 – The international medical imaging IT and cybersecurity company
Read more...STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's website:
Read more...22 August 2019
LUND, Sweden, Aug. 22, 2019 /PRNewswire/ -- "We are executing according to plan. Our lead candidate BI-1206 has shown encouraging initial data in hematological cancers, and has now also entered clinical trials in solid cancer," Martin Welschof, CEO BioInventFinancial informationSecond quarter 2019
Read more...STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi
Read more...CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's cabotegravir for the treatment of HIV. The study achieved its primary
Read more...22 August 2019
NEWARK, N.J., Aug. 22, 2019 /PRNewswire/ -- AGS Health (AGS), a leading provider of technology-enabled healthcare solutions to US healthcare providers, announced today the appointment of Ms. Patrice Wolfe as the company's new Chief Executive Officer (CEO). Patrice has in-depth expertise in building and scaling healthcare
Read more...OSLO, Norway, Aug. 22, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the second quarter and first half 2019. A presentation by the company's senior management team will take place today in Oslo at 08:30 CEST, see details below. Eduardo
Read more...
